| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.041 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |